Home » Topics » Regulatory » Patents

Patents
RSS

Kyowa Hakko's OXT displays cardiotonic and insulin release-promoting effects

July 5, 1996

NEP inhibitors claimed by Santen

July 5, 1996

AHP describes tricyclic benzazepine vasopressin antagonists

July 5, 1996

Warner-Lambert reports nonpeptide ET antagonists

July 5, 1996

Uriach research into PAF antagonists continues

July 5, 1996

Cephalon reveals multicatalytic protease inhibitors

July 5, 1996

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...